Pharmaceuticals Purchase Policy approved by the Union Cabinet

Oct 31, 2013 11:31 IST

The Union Cabinet on 30 October 2013 approved the five years Pharmaceuticals Purchase Policy (PPP). The PPP renewal has been approved to ensure finest utilization of the installed capacity of pharma of the Central Public Sector Enterprises (CPSEs).  

As per the policy, 103 medicines were validated for five years from the date of the issue of the orders by the Department of Pharmaceuticals. The pricing of the products would be done by the National Pharmaceutical Pricing Authority (NPPA) following the cost based formulae, as per the Drugs Price Control Order. Uniform discount of 16 percent on all products would be available.

The policy extended only to the Central Public Sector Enterprises (CPSEs) under the administrative control of Department of Pharmaceuticals, like the Hindustan Antibiotics, Indian Drugs and Pharmaceuticals, Karnataka Antibiotics and Pharmaceuticals, Rajasthan Drugs and Pharmaceuticals and Bengal Chemicals and Pharmaceuticals along with and their subsidiaries, where Governments holds minimum of 51 percent or more shares.

In the year 2006, the Cabinet approved the same type of policy for 102 medicines which are manufactured by the PSUs that expired in the year 2011.

Is this article important for exams ? Yes19 People Agreed

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK